12-6957776-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002831.6(PTPN6):c.1197G>A(p.Pro399=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00251 in 1,614,124 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 23 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 20 hom. )
Consequence
PTPN6
NM_002831.6 synonymous
NM_002831.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -6.31
Genes affected
PTPN6 (HGNC:9658): (protein tyrosine phosphatase non-receptor type 6) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. N-terminal part of this PTP contains two tandem Src homolog (SH2) domains, which act as protein phospho-tyrosine binding domains, and mediate the interaction of this PTP with its substrates. This PTP is expressed primarily in hematopoietic cells, and functions as an important regulator of multiple signaling pathways in hematopoietic cells. This PTP has been shown to interact with, and dephosphorylate a wide spectrum of phospho-proteins involved in hematopoietic cell signaling. Multiple alternatively spliced variants of this gene, which encode distinct isoforms, have been reported. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-6957776-G-A is Benign according to our data. Variant chr12-6957776-G-A is described in ClinVar as [Benign]. Clinvar id is 778582.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.31 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0118 (1795/152332) while in subpopulation AFR AF= 0.0388 (1611/41562). AF 95% confidence interval is 0.0372. There are 23 homozygotes in gnomad4. There are 871 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1795 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTPN6 | NM_002831.6 | c.1197G>A | p.Pro399= | synonymous_variant | 10/16 | ENST00000318974.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTPN6 | ENST00000318974.14 | c.1197G>A | p.Pro399= | synonymous_variant | 10/16 | 1 | NM_002831.6 | P1 | |
PTPN6 | ENST00000456013.5 | c.1197G>A | p.Pro399= | synonymous_variant | 10/16 | 1 | |||
PTPN6 | ENST00000399448.5 | c.1203G>A | p.Pro401= | synonymous_variant | 10/16 | 1 | |||
PTPN6 | ENST00000416215.6 | n.1605G>A | non_coding_transcript_exon_variant | 9/15 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0118 AC: 1791AN: 152214Hom.: 23 Cov.: 32
GnomAD3 genomes
AF:
AC:
1791
AN:
152214
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00352 AC: 878AN: 249246Hom.: 6 AF XY: 0.00270 AC XY: 366AN XY: 135326
GnomAD3 exomes
AF:
AC:
878
AN:
249246
Hom.:
AF XY:
AC XY:
366
AN XY:
135326
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00155 AC: 2262AN: 1461792Hom.: 20 Cov.: 36 AF XY: 0.00139 AC XY: 1011AN XY: 727200
GnomAD4 exome
AF:
AC:
2262
AN:
1461792
Hom.:
Cov.:
36
AF XY:
AC XY:
1011
AN XY:
727200
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0118 AC: 1795AN: 152332Hom.: 23 Cov.: 32 AF XY: 0.0117 AC XY: 871AN XY: 74498
GnomAD4 genome
AF:
AC:
1795
AN:
152332
Hom.:
Cov.:
32
AF XY:
AC XY:
871
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at